Substance Use Tools & Resources    

Highlights key findings about implementing evidence-based telehealth services, including legal and regulatory codes and professional ethical requirements

Assesses known opioid-related overdose risk behaviors.

This provincial evidence-based guideline articulates the full range of therapeutic options for the optimal treatment of adults and youth with varying presentations of opioid use disorder. It is intended for use for all British Colombia (BC) physicians, nursing and allied health professionals, and other care providers involved in the treatment of individuals with opioid use disorder. 

Provides a broad set of recommendations to prevent, treat, and support recovery from opioid misuse and addiction in Alaska.

Provides recommendations for safer and more effective prescribing of opioids for chronic pain in patients 18 and older in outpatient settings outside of active cancer treatment, palliative care, and end-of-life care.

Presents a business plan for health centers and practices who treat opioid use disorder (OUD).

Provides information for patients about the goals of detoxification and different detoxification programs.

Assists in the prediction of aberrant drug-related behavior among patients with chronic pain.

Provides a high-level overview of the potential for buprenorphine abuse and how to reduce the risks.

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.